Brief: Beta Drugs Achieves Regulatory Milestones In Azerbaijan And Philippines
22/04/2026 04:48
April 22 (Reuters) - Beta Drugs Ltd BTAD.NS: ACHIEVES REGULATORY MILESTONES IN AZERBAIJAN AND PHILIPPINES FACILITY INSPECTED BY AZERBAIJAN MINISTRY OF HEALTH; GMP APPROVAL EXPECTED IN 1-2 MONTHS RECEIVES CPR FOR 2 BRANDS IN PHILIPPINES Source text: ID:nNSE3HVT9m Further company coverage: BTAD.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Beta Drugs
See all newsBrief: Beta Drugs Receives Oncology Portfolio Approvals In Azerbaijan
India's Beta Drugs jumps after regulatory milestones in Azerbaijan, Philippines
Brief: Beta Drugs Achieves Regulatory Milestones In Azerbaijan And Philippines
Brief: Beta Drugs To Buy 66.09% Of Nivian Life Sciences For 694 MLN Rupees
Brief: Beta Drugs Receives Dcgi Approval For Methotrexate Oral Solution